![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 06, 2007 5:59:59 AM
ZYNX Revenue Forecast
Quarter Ending 2006 Mar 2007 Mar 2007 Jun 2007 Sep 2007 Dec 2008 Mar 2008 Jun 2008 Sep 2008 Dec 2009 Mar 2009 Jun 2009 Sep
Avg sales reps 10 26 26 34 50 56.63 67.15 80.81 99.71 124.43 157.51 202.32
Avg orders per rep 45 69 75.21 81.98 89.36 97.4 106.17 115.72 126.13 137.49 149.86 163.35
Orders during quarter 449 1812 1955.46 2787.28 4467.85 5515.64 7128.97 9351.35 12576.36 17106.83 23604.64 33047.79
Orders past two Q's 900 1700 2662 3767.46 4742.74 7255.13 9983.49 12644.61 16480.32 21927.71 29683.2 40711.48
Avg rentals out 450 1181.87 1468.5 2086.9 3042.71 4082.97 5418.7 7002.66 9295.17 12529.43 17154.76 23820.05
Sales $ per rep $10,000 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600 $9,600
Revenue from sales $100,000 $249,600 $249,600 $326,400 $480,000 $543,641 $644,639 $775,778 $957,176 $1,194,483 $1,512,102 $1,942,225
Revenue from rentals $400,500 $1,028,224 $1,277,594 $1,815,600 $2,647,156 $3,552,187 $4,714,271 $6,092,315 $8,086,795 $10,900,602 $14,924,641 $20,723,445
Projected revenue $500,500 $1,277,824 $1,527,194 $2,142,000 $3,127,156 $4,095,828 $5,358,910 $6,868,093 $9,043,971 $12,095,085 $16,436,743 $22,665,670
Net Sales $505,091 $1,336,731 $1,527,194 $2,142,000 $3,127,156 $4,095,828 $5,358,910 $6,868,093 $9,043,971 $12,095,085 $16,436,743 $22,665,670
Cost of Sales $16,393 $99,635 $113,831 $159,657 $233,087 $305,288 $399,433 $511,922 $674,104 $901,523 $1,225,134 $1,689,415
Gross Profit $488,698 $1,237,096 $1,413,363 $1,982,343 $2,894,070 $3,790,540 $4,959,477 $6,356,170 $8,369,867 $11,193,562 $15,211,609 $20,976,255
Gross Margin 96.75% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55% 92.55%
Fixed SG&A $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228 $376,228
Relative SG&A $101,390 $408,262 $440,585 $628,003 $1,006,651 $1,242,728 $1,606,229 $2,106,952 $2,833,581 $3,854,341 $5,318,363 $7,445,997
Other $20,197 $29,838 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000
Interest $13,318 $122,083 $40,000 $40,000 $40,000 $40,000 $40,000 $40,000 $40,000 $40,000 $40,000 $40,000
Total Expenses $511,133 $936,411 $886,813 $1,074,231 $1,452,879 $1,688,956 $2,052,457 $2,553,180 $3,279,809 $4,300,569 $5,764,591 $7,892,225
Before Tax Income ($22,435) $300,685 $526,550 $908,113 $1,441,190 $2,101,584 $2,907,020 $3,802,990 $5,090,058 $6,892,993 $9,447,018 $13,084,030
Tax Rate 0.00% 35.00% 35.00% 27.00% 27.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00%
Net Income ($22,435) $195,445 $342,258 $662,922 $1,052,069 $1,366,029 $1,889,563 $2,471,943 $3,308,538 $4,480,446 $6,140,562 $8,504,620
Shares Outstanding 23208000 27399000 27399000 27399000 27399000 27399000 27399000 27399000 27399000 27399000 27399000 27399000
EPS -$0.001 $0.007 $0.012 $0.024 $0.038 $0.050 $0.069 $0.090 $0.121 $0.164 $0.224 $0.310
FW P/E Ratio 24 20 20 20 20 20 20 20 18 16 14 12
Share Price -$0.09 $0.57 $1.00 $1.94 $3.07 $3.99 $5.52 $7.22 $8.69 $10.47 $12.55 $14.90
Organic Growth Rate Quarterly 9.00%
Cost Per Rep 100000
Recent ZYXI News
- Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 • PR Newswire (US) • 06/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:24:18 PM
- Zynex to Present at the RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/09/2024 01:15:00 PM
- Zynex Executives Recognized Among Top 25 in Medical Technology • PR Newswire (US) • 05/07/2024 01:15:00 PM
- Zynex Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:01:00 PM
- Zynex Sets First Quarter 2024 Earnings Call • PR Newswire (US) • 04/18/2024 01:15:00 PM
- Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award • PR Newswire (US) • 04/02/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:15:17 PM
- Zynex Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:01:00 PM
- Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call • PR Newswire (US) • 02/22/2024 02:15:00 PM
- Zynex Introduces New Products • PR Newswire (US) • 02/20/2024 02:15:00 PM
- Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 • GlobeNewswire Inc. • 02/08/2024 02:00:00 PM
- Zynex Receives FDA Clearance for its Next Generation NMES Device • PR Newswire (US) • 02/06/2024 02:15:00 PM
- Zynex Recognized in Top 25 Medical Device Companies for 2024 • PR Newswire (US) • 02/02/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 10:55:32 PM
- Zynex to Participate at the Needham Annual Growth Conference • PR Newswire (US) • 01/08/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:15:06 PM
- Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024" • PR Newswire (US) • 11/15/2023 02:15:00 PM
- Zynex Submits FDA Application for its Next Generation NMES Device • PR Newswire (US) • 11/13/2023 02:15:00 PM
- Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year • PR Newswire (US) • 11/09/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:20:20 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM